Digital Library/Neuropsychopharmacology – 5th Generation of Progress
Published in 2002, the Fifth Edition synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. Nine sections focus on specific groups of disorders–disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer’s and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation.
Neuropsychopharmacology: The Fifth Generation of Progress Editors:
Kenneth L. Davis
Joseph T. Coyle
Lippincott, Williams, & Wilkins, Philadelphia, Pennsylvania, 2002
Study Finds Nerve Cells Control Their Own Release of “Happy Hormone” Dopamine http://ow.ly/ZDie50EpLg3 #mentalhealth #dopamine #Botox @nyugrossman
Dr. Baram will lead a collaborative research team to discover for each child a marker that can predict their level of resilience, so that targeted interventions can be delivered to children who need them most. 4/